followed in tumour-bearing mice after application of either 5-fluorouracil (FU) alone or of FU followed by cold TdR infusion. With FU alone, accumulation of cells at the beginning of S was found, but there was no indication of a synchronous passage of the accumulated cells further round the cycle. When FU injection was followed by cold TdR infusion, a synchronous passage of the accumulated cells through the cycle was observed. However, there was a large variation in the response of individual mice to this treatment.
IN recent years, the concept of cellcycle-specific therapy of tumours following synchronization of the tumour cells has found increasing attention. Three substances which have been used clinically to achieve synchrony are hydroxyurea (Sauer, Pelka and Wilmanns, 1976) , vincristine (Klein and Lennartz, 1974) and 5-fluorouracil (FU) (Nitze, Ganzer and Vosteen, 1974) . However, the efficacy of vincristine as a synchronizing agent has been disputed (Jellinghaus et al., 1975) . In addition, Wannenmacher et al. (1974) were unable to confirm the results obtained by Nitze et al. (1974) with FU.
As this form of clinical synchronization therapy is being widely used, it was decided to carry out the present study with FU. The aim of the present study was to see if in vivo synchrony can, in fact, be achieved with FU. For this purpose, the mouse L1210 leukaemia was used and the study was carried out in two parts. In the first part the effect of FU alone on the tumour cells was studied. In the second part FU injection was followed by a constant infusion of cold TdR. This was done to see whether the degree of synchrony could be improved by cold TdR infusion. The possibility of improving synchrony with cold TdR in vitro has already been demonstrated (Eidinoff and Rich, 1959; Rueckert and Mueller, 1960) .
In a strict sense one can speak about synchronization only if two important conditions are fulfilled. The first condition is that an efficient accumulation of cells at a particular point in the cell cycle be produced. As is described later, the action of FU meets this condition, at least in part. However, it will also be seen that the action of FU alone does not meet the second condition, that after a suitable time a rapid dissolution of the block occurs, leading to a sharp release of accumulated cells and their subsequent synchronous passage round the cycle.
MATERIAL AND METHODS

5-Fluorouracil (FU) was obtained from
Hoffmann-La Roche, Grenzach/Baden.
[3H-Methyl] thymidine ([3H]-TdR, sp. act. 6-7 Ci/mmol) and [3H-6] -deoxyuridine [3H]-UdR, sp. act. 25-9 Ci/mmol) were obtained from New England Nuclear Chemicals, Boston, Mass., USA.
Cold TdR was purchased from the Sigma Chemical Company, St Louis, USA.
Animals.-The experiments were carried out on female B6D2 Fl mice (Laboratory of Animal Breeding and Research Centre, GI Bomholtgard Ltd, Ry, Denmark). The mice weighed 20-27 g. They were kept under constant conditions (12-h light-dark regime, Altromin R standard food, water ad lib.).
Transplantation of L1210 ascites tumour.-Initially the tumour was transplanted at 6-day intervals. Ascitic fluid was pooled from 3 mice. Each recipient mouse received 105 cells i.p. in a volume of 0-1 ml. Experiments were begun on the 5th day after transplantation.
The above method was used for the part of the study which will be described first. After 180 passages the L1210 cell line maintained in this institute ceased to grow normally, and new cells had to be obtained from Dr Bierling, Inst. f. Onkologie und Immunologie, Hauptfabriken Bayer, Wuppertal-Elberfeld, Germany.
For the second part of the study (cold TdR infusion experiments), the transplantation procedure carried out at Bayer was adopted. The tumour was transplanted at weekly intervals and each recipient mouse received 2 x 105 cells in a volume of 0-2 ml. Experiments were begun on the 6th day after transplantation. The mean survival time of mice transplanted in this way is 12-5 days. During the experimental period, the mitotic index remained constant in untreated animals and there was only a small fall in labelling index.
Constant infusion technique.-The constant infusion technique was carried out as described by Lobbecke, Schultze and Maurer (1969) . A catheter was inserted into the tail vein of mice on the day before the experiment began. For 24 h before the start of the experiment physiological saline was infused. At the appropriate time, the infusion medium for mice to receive cold TdR was changed to TdR solution (36 mg TdR in 20 ml 5 % glucose solution). The control mice (without TdR) were maintained for the duration of the experiment on the physiological saline infusion. All infusions were given at a rate of 2-4 ml/day. During the experiment the mice were able to move around freely, and eat and drink at will.
To obtain samples of ascites fluid from the mice under constant infusion, a smallbore needle (Nr. 18 or 20) was carefully inserted into the peritoneal cavity and one drop of ascites fluid withdrawn. This procedure was repeated 8-10 times during the course of the experiment. Histology and autoradiography.-Smears were prepared from the ascites, air-dried, fixed in methanol and Feulgen-stained. Autoradiographs were prepared by the dipping technique, with Ilford K2 emulsion. They were exposed at 4°C and developed with Amidol.
Evaluation of slides. Mitotic and labelling indices were determined by counting a minimum of 1000 cells for each animal or, in the case of multiple-sampled mice, 1000 cells for each individual sample.
Biochemical action of 5-fluorouracil
The main effect of FU is to block the enzyme TdR synthetase (TS), which by methylation converts deoxyuridine phosphate to deoxythymidine phosphate (see Fig. 1 ). When deprived of deoxythymidine phosphate, cells are unable to synthesize DNA and therefore accumulate at the beginning of S. The active metabolite is not, however, FU itself but FUdRP. FU can also affect RNA synthesis, but the doses required to produce an observable effect on RNA synthesis are considerably higher (Heidelberger et al., 1960; Hartmann and Heidelberger, 1961 Cleaver, 1967) .
As can be seen in Fig. 1 (Eidinoff and Rich, 1959; Rueckert and Mueller, 1960 A dose of 0-1 jtg/g caused a sharp initial fall in mitotic index ( Fig. 2(a) ). In One ,tg/g and 10 ,ug/g FU had an effect on the mitotic index similar to that of 3 ,tg/g. Differences resulted, however, in the response of the [3H]-UdRlabelling index. Though there was a marked reduction in grain count per nucleus 1.5 h after a dose of 1 /ug/g, the labelling index was little affected; thus the block of TS was less effective than with a dose of 3 /tg/g. After application of 10 jtg/g FU, recovery of labelling index was much slower than after a dose of 3 ,ug/g. Ten hours after FU injection, only 10% [3H]-UdR-labelled cells were found (in contrast to nearly 80% labelled cells with 3 ,ug/g FU).
On the basis of these results, 3 ,ug/g FU was chosen as the most likely dose to give a synchronizing effect, as it caused a substantial initial block followed later by recovery of proliferative indices. This dose lies between the highest doses, which caused an irreversible block and resulted in cell killing, and the lower doses, which were less effective in blocking TS.
Action of 3 ,ug/g FU alone After the choice of 3 ,ug/g FU as the most suitable dose, more extensive studies of the mitotic index and the incorporation of [3H]-UdR and [3H]-TdR were made. Fig. 3 shows the results.
(a) Mitotic index.- Fig. 3 (a) demonstrates the mitotic index for singly sampled mice; groups of mice were killed at the various time points and a single sample of ascites fluid withdrawn. As can be seen, the curve shows a sharp decrease, reaching a minimum 8 h after injection of FU. This trough is followed by a slow rise to approximately normal values, with no evidence of a mitotic peak.
To see whether repeated withdrawal of ascites fluid affected the mitotic index per se, an experiment was carried out in which 4 mice were given 3 ,tg/g FU, Fig. 4 . The course of the mitotic index for multiply-sampled mice (points, Fig. 4 ) was found to be essentially the same as obtained from groups of singly-sampled mice (curve, Fig. 4) . Thus, multiple sampling as carried out here had no significant effect on the mitotic index.
UdR-labelling index curve is given in Fig. 3 To examine this possibility in vivo, FU injection in tumour-bearing mice was followed by constant infusion of cold TdR.
(a) Experimental design and results. Fig. 5 illustrates the experimental design and also the mean mitotic index curves obtained for a group of 8 experimental and 6 control mice. All mice were given 3 ,tg/g FU i.p. at the beginning of the experiment and again 2-5 h later. The second injection was given to ensure a maximum block for the 5-h period calculated to be necessary for entry of all G1, G2 and M cells into S. Continuous infusion of FU over this 5-h period was tried but found not to improve accumulation of cells at the beginning of S.
Five hours after the first FU injection, one group of 8 mice was infused i.v. with cold TdR, while a control group of 6 mice was maintained on physiological saline infusion. The rate of TdR infusion was 3 ,ug/mouse/min. This rate was calculated, from the work of Stewart et al. (1965) and Lee et al. (1976) to be sufficient to provide the mice with enough TdR for normal requirements in the absence of de novo synthesis. A drop of ascitic fluid was withdrawn from each mouse 8 times during a 28-h period. The mitotic index was determined for all samples.
The solid line (Fig. 5) indicates the course of the mitotic index for the mice which received FU followed by cold TdR: the points are mean values for the group of 8 mice; standard errors are shown. For comparison, the dotted line gives the resulting means for the group of 6 control mice given FU but no cold TdR. As can be seen, a peak mitotic index was obtained in the cold TdR-treated mice. In fact, the cold TdR group have a significantly higher mitotic index over the period 8 to 23 h after the first FU injection (MannWhitney test). The peak mitotic index in the cold TdR group occurred at 19 h after the first FU injection. This is 14 h after the beginning of the cold TdR infusion. If cells blocked at the beginning of S had passed at the normal rate around the cycle at the start of cold TdR infusion, they would have been expected to reach mitosis in a time equal to S + G2 + 1 M; this is about 8-9 h in this tumour. Thus, the peak of mitoses occurred somewhat later than expected.
(b) Mitotic results for individual mice infused with cold TdR.-The variation in response of individual mice to FU treatment followed by cold TdR infusion is seen in Fig. 6 . The mitotic curves for the 8 cold TdR mice are given by the solid lines. These are the individual curves, whose average is plotted as the solid line in Fig. 5 . Once again, for comparison, the mean curve for the control group is given in each case. As can be seen, not only does the height of the mitotic peak vary greatly, but also its timing and shape.
(c) Labelling index results.-In addition to the mitotic index measurements, [3H]-TdR-labelling indices were also determined in both the control and cold TdR groups of mice. It was, of course, only possible to measure the [3H]-TdR labelling index at one time for each mouse. The labelling index was measured in 4 mice, 5 h after the first FU injection. This was done to assess the percentage of cells accumulated at the beginning of S in this 5-h period. At the time of the mitotic peak in the cold TdR mice (Fig. 5) , 19 h after the first FU injection, the labelling index was also determined for groups of 4 control and 4 cold-TdR mice.
At the end of the FU block period (Table; 5h) approximately 70% labelled cells were seen. This is about 20% more than the normal value of 50% (Table; 0 h) and indicates an accumulation of 20% of the cells at the beginning of S. Nineteen hours after the first FU injection the control mice without cold TdR had a mean mitotic index of 1.8%, and no (Table; 19 h). This is further evidence that the cold TdR infusion had, indeed, led to a faster release of the cells blocked by FU. The accelerated passage of these cells through the S phase into mitosis leads to the mitotic peak shown in Fig. 5 (solid line).
DISCUSSION
Action of FU alone The mitotic and labelling results (Fig.  3(a-c) ) with FU alone, showed that we achieved a considerable, but not complete, block of cells at the beginning of the S phase. If a complete block had been achieved, the mitotic index would have reached zero. It is known that the rate of entry of cells into S in this tumour is 7%/h: thus, after 5 h one would have expected to have accumulated 35% of the cells at the beginning of S, if the block had been complete. The [3H]-TdR curve (Fig. 3(c) ) shows that, in fact, a little over 20% of the cells were accumulated. The [3H]-UdR-labelling results (Fig. 3(b) ) indicated that over the first 5 h after FU the block of TS was almost complete (only 10% very lightly labelled cells were seen at 5 h). The main factor preventing a better block is almost certainly the TdR available to the cells via the " thymidine salvage " pathway.
The [3H]-UdR and mitotic index curves ( Fig. 3(a) and (b) ) suggest that cells begin to escape from the block by about 10 h after application of FU, but this release is slow and gradual. There is no evidence (Fig. 3(c) ) of a second peak of labelled cells. Furthermore, no peak of mitotic index is seen after the labelling-index peak. Instead, the mitotic index rises slowly, reaching normal values 30 h after FU injection. If accumulated cells had been released sharply, they would have required a period equal to the duration of S and G2 to reach mitosis: about 8-9 h in the L1210 tumour.
Under this condition, a peak of mitotic activity would have been seen 16 to 20 h after FU. This was clearly not the case (Fig. 3(a) ). Thus, the cells accumulated at the beginning of S do not pass through mitosis in a synchronized wave, and it would seem that FU does not, at least in this study, fulfil the second requirement of a synchronizing agent (i.e. the accumulated cells do not escape sharply from the block and do not pass synchronously further round the cycle).
This failure of the accumulated cells to pass synchronously round the cycle could be due either to a slow dissolution of the block or to their sustaining permanent damage leading to a complete failure to proliferate further, and eventual death. With a dose of 3 ,ug/g FU, no cytological evidence of cell death was seen, in contrast to higher doses. Thus, the most likely explanation for the failure to achieve synchrony was a slow release of cells from the block. Schumann and Hattori (1975) found, with a hamster sarcoma cell line in vitro, that passage of cells round the cycle after FU treatment was markedly slowed. They found that cells which normally had an S phase of 8-1Oh required 72 h to pass from the beginning of S to G2 after FU.
A possible reason for the slow recovery of cells from the effects of FU may be the long life of active FU metabolites, particularly FUdRP, in the tissues. Although a large part of injected FU is excreted rapidly (Chaudhuri, Montag and Heidelberger, 1958) , evidence from studies with 14C-labelled FU suggests that active metabolites are present in the tissues for periods up to 72 h after injection (Chadwick and Rogers, 1972; Liss and Chadwick, 1974 ). FU has also been shown to have long-lasting effect on [3H]-UdR incorporation into tumour cells (Kovacs et al., 1975; Myers, Young and Chabner, 1975) . Myers et al. (1975) 
Effect of FU followed by cold TdR
When injection of FU was followed by constant infusion with cold TdR, evidence of a synchronized passage of cells round the cycle was seen. In all animals which received cold TdR, there was an increase in mitotic index in the period 3-18 h after the beginning of the TdR infusion. The mitotic peaks were, however, generally broad and fairly small (Fig. 6) . That the peaks were not higher is not surprising, in view of the fact that accumulation of cells by FU was only partial. Also, in view of the known variation of S phase duration in the L1210 tumour, considerable flattening of the mitotic peaks would be expected. The peak mitotic index in Fig. 5 occurred 14 h after the start of the cold TdR infusion. If the accumulated cells had passed through S and G2 at the normal rate, they would have been expected to reach mitosis 8-9 h later (S + G2). No firm explanation for this delay of about 5 h is available. One possibility is that the dose of cold TdR was not quite optimal, and therefore DNA synthesis took longer than normal. It is possible that, if a slightly higher dose had been given, the peak of mitoses would have been seen earlier. A range of cold TdR doses was not tested, simply due to the practical limitations of the constant infusion technique, which allows only a small number of mice to be infused at any one time.
In vitro and in vivo studies with animals
It has clearly been shown in vitro that the growth-blocking effect of FU or FUdR on proliferating cultured cells can be prevented by supplying the cells with exogenous TdR (Brinkmann and Dormer, 1972; Madoc-Jones and Bruce, 1968; Rich et al., 1958; Umeda and Heidelberger, 1968) . Further, cells accumulated at the beginning of the S phase by these compounds have been shown, when released from this block by added TdR, to proceed in a partially synchronized wave round the cell cycle, at least as far as the subsequent mitosis (Eidinoff and Rich, 1959; Rueckert and Mueller, 1960) .
In vivo studies in animals of the problem of synchronization with FU are few in number. Jentzsch (1975) , using a dose of 13 ,ug/g FU with the rat Walker tumour, found no effect on mitotic or labelling index. An effect on the PLM* curve in animals given FU compared with controls was found, but is difficult to explain. Nitze (1970) and Nitze et al (1974) reported investigations on chemically induced skin tumours of * % labelled metaphases.
mice. In these studies, life-span of the animals and rate of growth of the tumours were assessed for 5 groups of mice.
One group (" combination therapy group) received FU and irradiation separated by an interval of one day, while another group (" synchronously " treated group) received FU over a 12-h period followed 8 h later by irradiation. It was assumed that the cells accumulated by FU escaped sharply from the block and passed in 8 h through S into the radiosensitive G2 phase. It was found that the second, so-called " synchronously treated ", group had a longer survival time and that the tumours in this group grew more slowly than in the " combination therapy " group. These differences were ascribed to the effect of FU-induced synchronization. However, no direct evidence that synchrony had, in fact, been achieved was presented (e.g. no labelling or mitotic studies). There is no doubt that there are timing factors other than those relating to synchrony, which are important for the success of combination therapy. Thus caution should be exercized in ascribing effects such as those described above to synchrony. Clinical studies with FU FU has been used in the treatment of malignant tumours for many years, and there is no doubt that with certain types of tumour its use, either alone or in combination, can be clinically valuable. The literature on the clinical use of FU, particularly as part of combination therapy schedules, is extensive. Its clinical use as a synchronizing agent is, however, more recent. Extensive investigations in this area have been made by Nitze and co-workers (Ganzer and Nitze, 1969; Nitze et al., 1974) . The results of these studies are reviewed in the paper from Nitze et al. (1974) . In these studies FU was infused into tumourbearing patients for a period of 12 have expected a more dramatic fall in mitotic index. The main evidence that synchrony had been achieved was a small mitotic peak 9 h after the end of the FU block. This peak was, however, small and its statistical significance doubtful. The timing of the peak is also of interest: the authors assumed an S-phase duration of 8h, and they also assumed that the accumulated cells immediately after FU infusion began their passage round the cycle at the normal rate. From a survey of the literature, the assumption concerning the duration of S would not seem too secure. In human tumours this has generally been shown to be considerably longer than 8 h (see for example Malaise, Chavaudra and Tubiana, 1973) . The assumption that the cells at the end of the block immediately begin to cycle at the normal rate is, from the results presented in this paper, equally doubtful.
Wannenmacher et al. (1974) treated 23 patients with squamous cell carcinoma with the therapeutic scheme of Nitze et al. (1974) . Impulse cytophotometry was used to follow the kinetic changes in the tumours after FU infusion. In 15 of these patients there was no evidence of a synchronized passage of cells into the radiosensitive G2 phase after FU. Even in the 8 patients in which an increased G2 population was seen, this occurred, not 9h after FU infusion, as was assumed by Nitze et al. (1974) , but considerably later.
As a result of our present studies and those reported in the literature, it is felt that the claims by Nitze et al. (1974) that synchronization can be achieved in vivo in patients, and that their timing schedule is optimal for synchronization therapy, should be treated with caution. That the treatment schedule reported by Ganzer et al. (1974) may yield good clinical results is not disputed and has been confirmed by other authors (Helpap et al., 1977; Wannenmacher et al., 1974) . However, as pointed out by these other authors, the positive clinical results probably depend upon factors other than synchronization.
The present study with the L1210 tumour suggests that synchrony in vivo with FU is not easily achieved, due to three main factors. Firstly, the block is incomplete, probably due to the " thymidine salvage pathway ". Secondly, cells escape only slowly and gradually from the effects of FU. Thirdly, there is a high degree of variation in response of individual tumours to the drug. When FU was followed by constant infusion of cold TdR, a small degree of synchrony was achieved in this investigation with mice. However, there was great variation in the response of individual animals. One would expect an even greater variation between slowly growing human solid tumours. Even if synchrony could be achieved clinically, this variation would make it very difficult to develop treatment schedules of general relevance. 
